FDA Orange Book
Is there a generic for Valtoco?
Valtoco contains diazepam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Valtoco (diazepam). The Orange Book shows its last listed patent expires June 10, 2042 and its last listed exclusivity ends April 15, 2028.
Run it in Rivvi
Map Valtoco and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Valtoco products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| spray, nasal | 10MG/SPRAY | Marketed (Rx) | None | 0 | None |
| spray, nasal | 5MG/SPRAY | Marketed (Rx) | None | 0 | None |
| spray, nasal | 7.5MG/SPRAY | Marketed (Rx) | None | 0 | None |
NDA 211635, held by NEURELIS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Valtoco patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 12521400 | March 27, 2029 | Drug product | None | 211635 |
| 11793786 | March 27, 2029 | Drug product | None | 211635 |
| 12268664 | March 27, 2029 | Drug product | None | 211635 |
| 8895546 | March 27, 2029 | Drug product | None | 211635 |
| 11241414 | March 27, 2029 | Drug product | None | 211635 |
| 12337061 | June 13, 2032 | Method of use | U-4173 | 211635 |
| 12324852 | October 16, 2032 | Method of use | U-4173 | 211635 |
| 12599611 | June 10, 2042 | Method of use | U-4455 | 211635 |
Valtoco exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| ODE-279 | Orphan drug exclusivity | January 10, 2027 | 211635 |
| NPP | New patient population | April 15, 2028 | 211635 |
Valtoco NDC codes
Questions
Is there a generic for Valtoco?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Valtoco (diazepam). The Orange Book shows its last listed patent expires June 10, 2042 and its last listed exclusivity ends April 15, 2028.
What is the generic name for Valtoco?
The active ingredient in Valtoco is diazepam, per the FDA Orange Book.
When does the Valtoco patent expire?
The last patent listed for Valtoco in the Orange Book expires June 10, 2042. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Valtoco and Diazepam
- What is Valtoco used for?FDA label uses
- Is Valtoco a controlled substance?Schedule IV
- What is Diazepam used for?FDA label uses
- Is Diazepam a controlled substance?Schedule IV
- Generic for DiastatFDA Orange Book
- Generic for Diastat AcudialFDA Orange Book
- Generic for ValiumFDA Orange Book
- Benzodiazepines listFDA drug class
- NDC 72252-505Valtoco NDC record
- NDC 72252-510Valtoco NDC record
- NDC 72252-515Valtoco NDC record
- Schedule IV drugs listDEA schedule